A Drug Utilization Study to Evaluate Indicators of Adherence to the Risk Minimization Measures for Ritlecitinib Using Electronic Healthcare Data in Denmark, France, and Sweden

ENCePP Code of conduct

No information provided.

Data sources

• Data source(s):
  Système National des Données de Santé (French national health system main database)
• Data source(s), other:
  Denmark's population-based registers; Sweden's population-based registers
• Data sources (types):
  Population registry

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Unknown

Procedures

No information provided.